BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11437636)

  • 1. Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-kappaB.
    Kanekiyo M; Itoh N; Kawasaki A; Tanaka J; Nakanishi T; Tanaka K
    Toxicol Appl Pharmacol; 2001 Jun; 173(3):146-53. PubMed ID: 11437636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.
    Caposio P; Luganini A; Hahn G; Landolfo S; Gribaudo G
    Cell Microbiol; 2007 Aug; 9(8):2040-54. PubMed ID: 17419715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
    Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J
    Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy to identify the regulatory DNA-organized cooperations among transcription factors.
    Niu G; Huang L; Wang Q; Jiang L; Huang M; Shen P; Fei J
    FEBS Lett; 2006 Jan; 580(2):415-24. PubMed ID: 16376876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.
    Boomker JM; The TH; de Leij LF; Harmsen MC
    Virus Res; 2006 Jun; 118(1-2):196-200. PubMed ID: 16448715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
    Prösch S; Wuttke R; Krüger DH; Volk HD
    Biol Chem; 2002 Oct; 383(10):1601-9. PubMed ID: 12452437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts.
    Butcher HL; Kennette WA; Collins O; Zalups RK; Koropatnick J
    J Pharmacol Exp Ther; 2004 Aug; 310(2):589-98. PubMed ID: 15039454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.
    Khan KA; Coaquette A; Davrinche C; Herbein G
    J Immunol; 2009 Jun; 182(12):7784-94. PubMed ID: 19494302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.
    Prösch S; Staak K; Stein J; Liebenthal C; Stamminger T; Volk HD; Krüger DH
    Virology; 1995 Apr; 208(1):197-206. PubMed ID: 11831701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.
    Isern E; Gustems M; Messerle M; Borst E; Ghazal P; Angulo A
    J Virol; 2011 Feb; 85(4):1732-46. PubMed ID: 21106746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
    Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
    Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway.
    Chen FH; Crist SA; Zhang GJ; Iwamoto Y; See WA
    J Urol; 2002 Aug; 168(2):786-97. PubMed ID: 12131369
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID: 8806515
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.